LEADER 08557nam 2200745Ia 450 001 9911091513403321 005 20260415135224.0 010 $a9781283856805 010 $a1283856808 010 $a9783110224641 010 $a311022464X 024 7 $a10.1515/9783110224641 035 $a(CKB)2670000000317674 035 $a(EBL)893985 035 $a(OCoLC)823284289 035 $a(SSID)ssj0000787582 035 $a(PQKBManifestationID)11501106 035 $a(PQKBTitleCode)TC0000787582 035 $a(PQKBWorkID)10817350 035 $a(PQKB)11424747 035 $a(MiAaPQ)EBC893985 035 $a(DE-B1597)38143 035 $a(OCoLC)992506956 035 $a(OCoLC)994350541 035 $a(DE-B1597)9783110224641 035 $a(Au-PeEL)EBL893985 035 $a(CaPaEBR)ebr10634488 035 $a(CaONFJC)MIL416930 035 $a(Perlego)653388 035 $a(EXLCZ)992670000000317674 100 $a20121227d2012 uy 0 101 0 $aeng 135 $aurnn#---|u||u 181 $ctxt 182 $cc 183 $acr 200 00$aAdvances in clinical chemistry and laboratory medicine /$fedited by Harald Renz and Rudolf Tauber 205 $a1st ed. 210 $aBerlin ;$aBoston $cDe Gruyter$dc2012 215 $a1 online resource (164 p.) 300 $a"A selection of papers ... delivered at the IFCC WorldLab/EuroMedLab Congress in Berlin, Germany, on May 15-19, 2011. 311 0 $a9783111739502 311 0 $a3111739503 311 0 $a9783110224634 311 0 $a3110224631 320 $aIncludes bibliographical references and index. 327 $tFront matter --$tPreface --$tTable of Contents --$tAuthors Index --$t1 Plenary Articles --$t1.1 Proteomics strategies targeting biomarkers for cardiovascular disease /$rScholten, Arjen / Heck, Albert J.R. --$t1.2 Influence of pre-examination aspects on result's validity - are ISO 15189 requirements sufficient and clear? /$r?prongl, Lud?k --$t1.3 Posttranslational modifications in tumor diagnosis /$rNollau, Peter / Wagener, Christoph --$t1.4 Chronic inflammatory disease: a result of complex gene-environment interaction /$rRenz, Harald / Pfefferle, Petra Ina / Garn, Holger --$t2 Symposium Articles --$t2.1 Component-array technology diagnostics: a step forward in the study of the sensitization profile of allergic patients /$rAcedo Sanz, Juan Manuel --$t2.2 Pediatric metabolic syndrome: pathophysiology and molecular mechanisms /$rChemin, Julie / Adeli, Khosrow --$t2.3 Urinary 8-hydroxydeoxyguanosine as a biomarker of microangiopathic complications in type 2 diabetic patients /$rFattouh, Amr / Mahmoud, Nermine H. / Atef, Shereen H. / Gaber, Abd El Rahman --$t2.4 Biological variation data: the need for appraisal of the evidence base /$rBartlett, William A. --$t2.5 Recovery ELISA - a newly-developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy /$rStrohner, Pavel / Sarrach, Dieter / Reich, Jens G. / Staatz, Antonia / Schäfer, Astrid / Steiß, Jens-Oliver / Häupl, Thomas / Becher, Gunther --$t2.6 Genotypic prediction of HIV-1 tropism from plasma and peripheral blood mononuclear cells in the clinical routine laboratory /$rPaar, Christian / Geit, Maria / Stekel, Herbert / Berg, Jörg --$t2.7 Expression of a subset of microRNAs in clinically non-functioning pituitary adenomas correlates with tumor size /$rButz, Henriett / Likó, István / Czirják, Sándor / Igaz, Péter / Korbonits, Márta / Rácz, Károly / Patócs, Attila --$t2.8 Serological markers of gastric pathology /$rCaleffi, Alberta --$t2.9 BNP as a biomarker of cardiac impairment in neonates with congenital heart diseases /$rCantinotti, Massimiliano / Murzi, Bruno / Storti, Simona / Clerico, Aldo --$t2.10 Are 25-hydroxyvitamin D assays fit for purpose? /$rCarter, Graham D. --$t2.11 Update on multiple sclerosis /$rCross, Anne H. --$t2.12 Microalbuminuria and urinary retinol binding protein as markers of subtle renal injury in visceral leishmaniasis: sensitivity, specificity and predictive values of the immunoturbidimetric technique /$rElnojomi, Nuha A.A. / Musa, Ahmed M. / Younis, Brima M. / Elfaki, Mohammed E. / El-Hassan, Ahmed M. / Khalil, Eltahir A. --$t2.13 Occult hepatitis B virus infection: diagnosis and significance /$rGerlich, Wolfram Hubert / Schüttler, Christian Gisbert / Glebe, Dieter --$t2.14 Unmet needs in chronic kidney disease testing /$rJones, Graham --$t2.15 Towards a national chronic kidney disease testing program /$rJones, Graham --$t2.16 Biochemistry and metabolism of vitamin D /$rJones, Glenville --$t2.17 Diagnostics of thalassemia /$rKaeslin, Martha / Brunner-Agten, Saskia / Huber, Andreas R. --$t2.18 The specific roles of assessors during accreditation /$rHuisman, Wim --$t2.19 Laboratory diagnosis of hereditary spherocytosis /$rKing, May-Jean --$t2.20 Quantification of blood folate forms using stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry /$rKirsch, Susanne H. / Herrmann, Wolfgang / Obeid, Rima --$t2.21 Evaluation of the new Marburg cerebrospinal fluid model with human spondylopathies /$rKleine, Tilmann Otto / Löwer, Christa / Bien, Siegfried / Lehmitz, Reinhardt / Dorn-Beineke, Alexandra --$t2.22 E-learning experiences of national societies of clinical chemistry and laboratory medicine /$rKocna, Petr --$t2.23 The experience of Médecins Sans Frontičres in laboratory medicine in resource-limited settings /$rKosack, Cara S. --$t2.24 Screening, identifying, and quantifying small molecules by hyphenated mass spectrometry in toxicology and drug monitoring - an update /$rMaurer, Hans H. --$t2.25 Analytical quality in the Latin America area /$rMigliarino, Gabriel Alejandro --$t2.26 Standardization in molecular diagnostics: definitions and uses of nucleic acid reference materials /$rPayne, Deborah A. / Rousseau, François / Mamotte, Cyril D.S. / Gancberg, David / Schaik, Ron H.N. van / Schimmel, Heinz / Pazzagli, Mario --$t2.27 Profiling of antiphospolipid antibodies - association with cerebrovascular events in APS /$rRoggenbuck, Dirk --$t2.28 Plasma levels of soluble CD30 and CD40L in pediatric patients after liver transplantation /$rShevchenko, Olga P. / Tsirulnikova, Olga M. / Gichkun, Olga E. / Kurabekova, Rivada M. / Ammosov, Aleksandr A. / Gautier, Sergey V. --$t2.29 Diagnostic and prognostic value of presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST presepsin /$rSpanuth, Eberhard / Ebelt, Henning / Ivandic, Boris / Werdan, Karl --$t2.30 Diagnostic workup of primary aldosteronism /$rStowasser, Michael --$t2.31 What should the clinical laboratory and the toxicologist-pharmacologist offer the poisoned patient? /$rUges, Donald R.A. --$t2.32 Novel aspects of the von Willebrand factor - platelet glycoprotein IB interaction and signaling /$rWalter, Ulrich / Gambaryan, Stepan / Herterich, Sabine / Lohmann, Suzanne M. --$t2.33 Medical emergencies: what is the laboratory's role? /$rYoung, Donald S. 330 $aIm Mai 2011 fand in Berlin der Weltkongress WorLdMedLab und Euromedlab mit ca. 5.000 Teilnehmern statt. Der von den Kongresspräsidenten Prof. Renz und Prof. Tauber herausgegebene Proceedingsband enthält Beiträge zu allen Plenar- und Symposiumsbeiträgen. Hochrangige Beiträger spiegeln das aktuelle Wissen zu Themenschwerpunkten wie neurologische Erkrankungen in einer alternden Gesellschaft, Tumore, organspezifische Funktionsstörungen und die Zukunft der Labormedizin wider. 330 $aThis volume comprises the invited plenary lectures and contributed papers presented at the WorldMedLab and the EuroMedLab in Berlin, May 2011 with more than 5.000 participants. The contributions in this volume provide a valuable and wide-ranging overview of current research in Laboratory Medicine and cognate disciplines. Special focus is given to Aging Society (neurological diseases), Tumors, Organ specific dysfunctions and Future of Laboratory Medicine. 606 $aClinical chemistry$vCongresses 606 $aDiagnosis, Laboratory$vCongresses 615 0$aClinical chemistry 615 0$aDiagnosis, Laboratory 676 $a616.075 686 $aYV 3300$2rvk 701 $aRenz$b H$g(Harald)$01983297 701 $aTauber$b Rudolf$01986658 712 12$aIFCC WorldLab 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911091513403321 996 $aAdvances in clinical chemistry and laboratory medicine$94761435 997 $aUNINA LEADER 03565nam 2200829Ia 450 001 9911107604803321 005 20251117100624.0 010 $a9781784020002 010 $a1784020001 010 $a9780748647439 010 $a0748647430 024 7 $a10.1515/9780748647439 035 $a(CKB)2670000000358115 035 $a(EBL)1183044 035 $a(OCoLC)850154427 035 $a(SSID)ssj0000971274 035 $a(PQKBManifestationID)11594523 035 $a(PQKBTitleCode)TC0000971274 035 $a(PQKBWorkID)10940754 035 $a(PQKB)10286986 035 $a(MiAaPQ)EBC1183044 035 $a(Au-PeEL)EBL1183044 035 $a(CaPaEBR)ebr10695133 035 $a(CaONFJC)MIL485813 035 $a(DE-B1597)616872 035 $a(DE-B1597)9780748647439 035 $a(PPN)185420389 035 $a(Perlego)1708479 035 $a(iGPub)EUPB0003265 035 $a(EXLCZ)992670000000358115 100 $a20130511d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aGothic literature /$fAndrew Smith 205 $a2nd ed. 210 $aEdinburgh $cEdinburgh University Press$dc2013 215 $a1 online resource (267 p.) 225 0 $aEdinburgh critical guides to literature 300 $aDescription based upon print version of record. 311 08$a9780748647415 311 08$a0748647414 311 08$a9780748647422 311 08$a0748647422 320 $aIncludes bibliographical references and index. 327 $a""Cover""; ""Copyright""; ""Contents""; ""Series Preface""; ""Acknowledgements""; ""Chronology""; ""Introduction""; ""1 The Gothic Heyday,1760a???1820""; ""2 The Gothic, 1820a???1865""; ""3 Gothic Proximities, 1865a???1900""; ""4 Twentieth Century""; ""5 Contemporary Gothic""; ""Conclusion""; ""Student Resources""; ""Index"" 330 $aNew edition of bestselling introductory text outlining the history and ways of reading Gothic literature.This revised edition includes: A new chapter on Contemporary Gothic which explores the Gothic of the early twentieth century and looks at new critical developments An updated Bibliography of critical sources and a revised Chronology The book opens with a Chronology and an Introduction to the principal texts and key critical terms, followed by five chapters: The Gothic Heyday 1760-1820; Gothic 1820-1865; Gothic Proximities 1865-1900; Twentieth Century; and Contemporary Gothic. The discussion 410 0$aEdinburgh Critical Guides to Literature 606 $aGothic revival (Literature)$zGreat Britain 606 $aGothic revival (Literature)$zUnited States 606 $aEnglish literature$y18th century$xHistory and criticism 606 $aEnglish literature$y19th century$xHistory and criticism 606 $aAmerican literature$y18th century$xHistory and criticism 606 $aAmerican literature$y19th century$xHistory and criticism 615 0$aGothic revival (Literature) 615 0$aGothic revival (Literature) 615 0$aEnglish literature$xHistory and criticism. 615 0$aEnglish literature$xHistory and criticism. 615 0$aAmerican literature$xHistory and criticism. 615 0$aAmerican literature$xHistory and criticism. 676 $a809.38729 676 $a820.911 700 $aSmith$b Andrew$f1964-$0741162 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911107604803321 996 $aGothic literature$94758276 997 $aUNINA